论文部分内容阅读
中药治疗急症具有悠久的历史和丰富的经验。但是,由于受中药剂型的限制,使得中医急症的发展相当缓慢,而没有形成完整的中医急症治疗学。可见,中药剂型的改革直接决定着中医急症的发展进程。本文通过回顾近二十年中医急症的中药剂型改革概况,提出了改革中特别应注意的一些问题。一、中医急症的中药剂型改革概况近二十年来,急症的中药剂型改革取得了较大的成就。据不完全统计,到目前为止,公开发表的各级卫生部门批准生产的中药急症制剂约350种左右,其中部分品种疗效显著,具备完整的药理、临床和质检的全部基础资料。经改革后的中药急症剂型包括注射
Chinese medicine has a long history and rich experience in the treatment of emergencies. However, due to the limitations of Chinese medicines, the development of acute medical emergencies is rather slow, and a complete Chinese medicine emergency treatment is not formed. It can be seen that the reform of Chinese pharmaceuticals directly determines the development process of TCM emergencies. This article reviews some of the issues that need special attention in the reforms by reviewing the overview of Chinese pharmaceutical emergency in recent two decades. I. Overview of China’s acute disease-type pharmaceutical reform In the past two decades, China’s emergency pharmaceutical reform has made great achievements. According to incomplete statistics, up to now, about 350 kinds of emergency preparations of Chinese medicine approved by various public health departments have been published, and some of these varieties have significant curative effects and possess complete basic data of pharmacological, clinical and quality inspections. The reformed Chinese medicine emergency dosage form includes injection